From the Editor's Desk

Boosting Vaccine Production Needs the Right Degree of Flexibility | INSEAD Knowledge

The pandemic has seen an unprecedented global effort to accelerate the development of safe and effective vaccines and a rapid expansion of vaccine manufacturing capacity. However, challenges in further scaling up vaccine manufacturing capacity to meet higher-than-expected demand and the resulting inequity in vaccine access have highlighted that our past investments in building vaccine surge capacity were insufficient. It is an issue vaccine companies, governments and multilateral agencies must face squarely in order to improve medium-term access to Covid vaccines as well as to gird humanity better against future pandemics.

Continued here

TradeBriefs: Newsletters for Decision-Makers!

Our advertisers help fund the daily operations of TradeBriefs. We request you to accept our promotional emails.

Want the newsletters, without the promotional mailers?
Get an (ad-free) subscription to TradeBriefs Premium for just $2 per month.